BioPharm Systems Unveils Study Data Mapper to Simplify the Preparation and Reporting of Clinical Data
Specifically developed for the life sciences industry,
"The overall efficiency of preparing clinical trials and programs for reporting and analysis can be greatly improved with Study Data Mapper," said Michael Grossman, vice president of
ICON plc, a global provider of outsourced development services to the pharmaceutical, biotechnology, and medical device industries, commissioned the development of Study Data Mapper, and is already using the application.
To learn more about Study Data Mapper, please call Rod Roderick at +1 877 654 0033 (U.S.) or Rudolf Coetzee at +44 (0) 1865 910200 (U.K.). You can also visit
BioPharm Systems is a Gold level member of Oracle PartnerNetwork (OPN) and an Oracle Accelerate solution provider. The company has achieved Specializations in Oracle Argus Safety Suite, Oracle Life Sciences Data Hub, and Oracle Accelerate for Midsize Companies.
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Related Articles
- IQVIA and Veeva Join Forces to Improve Efficiency and Patient Outcomes
September 17th 2025
- Managing Background Therapies in the NIMBLE Phase III Trial
September 17th 2025
- Generative AI Transforms Clinical Study Report Development
September 16th 2025